Prognosis After Discontinued Treatment due to Immune‐Related Adverse Events in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma

Documenti analoghi

• Qualitative Voice Analysis in Patients With Head and Neck Cancer Using the Provox Voice Prosthesis
  di: Ryota Iinuma, et al.
  Pubblicazione: (2025)
• Head and Neck Cancer Immunotherapy: Overcoming Limitations and Enhancing Efficacy
  di: Hirofumi Shibata, et al.
  Pubblicazione: (2025)
• Quantitative Assessment of Vestibular Function by Video Head Impulse Test and Vestibular‐Evoked Myogenic Potential During Cisplatin‐Based Chemoradiation
  di: Natsuki Takada, et al.
  Pubblicazione: (2025)
• First‐In‐Human Study: Dose Expansion of E7130 in Urothelial Carcinoma and Squamous Cell Carcinoma of the Head and Neck
  di: Nobuaki Matsubara, et al.
  Pubblicazione: (2026)
• A constructive counterpart of the subdirect representation theorem for reduced rings
  di: Kuroki, Ryota
  Pubblicazione: (2024)